Home/Pipeline/VitaSIRO solo MT‑RNR1 SNP Assay

VitaSIRO solo MT‑RNR1 SNP Assay

Genetic risk of aminoglycoside‑induced hearing loss

MarketActive

Key Facts

Indication
Genetic risk of aminoglycoside‑induced hearing loss
Phase
Market
Status
Active
Company

About Credo Diagnostics

Fast, affordable point‑of‑care PCR diagnostics for diverse clinical and veterinary applications.

View full company profile